TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biobank AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,233
|
1,239
|
1,381 |
| Financial expenses |
1
|
2
|
3 |
| Earnings before taxes |
74
|
172
|
35 |
| Total assets |
1,383
|
1,327
|
1,375 |
| Current assets |
1,232
|
1,161
|
1,148 |
| Current liabilities |
237
|
196
|
237 |
| Equity capital |
921
|
910
|
828 |
| - share capital |
25
|
27
|
28 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.6%
|
68.6%
|
60.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
6.0%
|
13.9%
|
2.5% |
| Return on assets (ROA) |
5.4%
|
13.1%
|
2.8% |
| Current ratio |
519.8%
|
592.3%
|
484.4% |
| Return on equity (ROE) |
8.0%
|
18.9%
|
4.2% |
| Change turnover |
57
|
-54
|
154 |
| Change turnover % |
5%
|
-4%
|
13% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.